FDA accepts AcelRx pain drug delivery tech for review; Researchers deliver drugs through membrane in the ear;

> AcelRx Pharmaceuticals ($ACRX) is hoping for an approval date in September next year after the FDA accepted its pain drug delivery system for regulatory review this week. More

> Researchers at the Rochester Institute of Technology have developed a delivery method for drugs via absorption through the round window membrane in the ear. Abstract

> Zogenix ($ZGX) and Batelle signed a 5-year contract for the use of Zogenix's DosePro needle-free drug delivery technology. More

Suggested Articles

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.

Kindeva, which produces inhalers, transdermal patches and other medical devices, is expanding operations in the St. Paul, Minnesota, area.